Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...
Everyday Health on MSN
Once-a-Week Insulin Shot Could Be a Game Changer for Type 2 Diabetes
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.
Pharmaceutical Technology on MSN
J&J’s Darzalex nets first self-administered cancer injectable approval
This approval will further enhance Darzalex’s penetration of the multiple myeloma market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results